Transient receptor potential channels in chemotherapy-induced neuropathy

Open Pain Journal

Volumn 6, Issue SPEC.ISSUE.1, 2013, Pages 127-136

  Nassini, Romina ^a   Benemei, Silvia ^a   Fusi, Camilla ^a   Trevisan, Gabriela ^a,b   Materazzi, Serena ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Anticancer drugs; Chemotherapy Induced Peripheral Neuropathy; Oxidative stress; Primary sensory neurons; Transient Receptor Potential Channels (TRP)

Indexed keywords

BORTEZOMIB; CISPLATIN; OXALIPLATIN; PACLITAXEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 4; VINCRISTINE;

ARTICLE; CELLULAR DISTRIBUTION; CHANNEL GATING; COLD NEUROPATHIC PAIN; CORRELATIONAL STUDY; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG INDUCED DISEASE; DYSESTHESIA; HYPERALGESIA; NERVE DEGENERATION; NERVE EXCITABILITY; NERVE STIMULATION; NEUROGENIC INFLAMMATION; NEUROPATHIC PAIN; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PARESTHESIA; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SENSORY NERVE CELL; SYMPTOMATOLOGY; TOXICOKINETICS;

EID: 84876092649     PISSN: None     EISSN: 18763863     Source Type: Journal    
DOI: 10.2174/1876386301306010127     Document Type: Article

References (156)

1. Wolf S, Barton D, Kottschade L, et al. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 2008; 44: 1507-15.
2. Connelly E, Markman M, Kennedy A, et al. Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity. Gynecol Oncol 1996; 62: 166-8.
3. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343-51.
4. McKeage MJ, Hsu T, Screnci D, et al. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer 2001; 85: 1219-25.
5. Grothey A. Oxaliplatin-safety profile: neurotoxicity. Semin Oncol 2003; 30: 5-13.
6. Pasetto LM, D'Andrea MR, Rossi E, et al. Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol 2006; 59: 159-68.
7. Dougherty PM, Cata JP, Cordella JV, et al. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004; 109: 132-42.
8. Rowinsky EK, Eisenhauer EA, Chaudhry V, et al. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 1993; 20: 1-15.
9. Weiss HD, Walker MD, Wiernik PH. Neurotoxicity of commonly used antineoplastic agents (second of two parts). N Engl J Med 1974; 291: 127-33.
10. Kaplan RS, Wiernik PH. Neurotoxicity of antineoplastic drugs. Semin Oncol 1982; 9: 103-30.
11. Richardson PG, Barlogie B, Berenson J, et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 2003; 348: 2609-17.
12. San Miguel JF, Schlag R, Khuageva NK, et al. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med 2008; 359: 906-17.
13. Frankland-Searby S, Bhaumik SR. The 26S proteasome complex: an attractive target for cancer therapy. Biochim Biophys Acta 2012; 1825: 64-76.
14. Morgan GJ, Krishnan B, Jenner M, et al. Advances in oral therapy for multiple myeloma. Lancet Oncol 2006; 7: 316-25.
15. Shishkin V, Potapenko E, Kostyuk E, et al. Role of mitochondria in intracellular calcium signaling in primary and secondary sensory neurones of rats. Cell Calcium 2002; 32: 121-30.
16. Chung JM. The role of reactive oxygen species (ROS) in persistent pain. Mol Interv 2004; 4: 248-50.
17. Joseph EK, Levine JD. Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 2004; 20: 2896-902.
18. Jaggi AS, Singh N. Mechanisms in cancer-chemotherapeutic drugsinduced peripheral neuropathy. Toxicology 2012; 291.
19. Flatters SJ, Xiao WH, Bennett GJ. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett 2006; 397: 219-23.
20. Kidd JF, Pilkington MF, Schell MJ, et al. Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore. J Biol Chem 2002; 277: 6504-10.
21. Siau C, Bennett GJ. Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg 2006; 102: 1485-90.
22. Pastorino JG, Snyder JW, Serroni A, et al. Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J Biol Chem 1993; 268: 13791-8.
23. Jin HW, Flatters SJ, Xiao WH, et al. Prevention of paclitaxelevoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol 2008; 210: 229-37.
24. Cavaletti G, Gilardini A, Canta A, et al. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat. Exp Neurol 2007; 204: 317-25.
25. Broyl A, Corthals SL, Jongen JL, et al. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial. Lancet Oncol 2010; 11: 1057-65.
26. Landowski TH, Megli CJ, Nullmeyer KD, et al. Mitochondrialmediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines. Cancer Res 2005; 65: 3828-36.
27. Melli G, Taiana M, Camozzi F, et al. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol 2008; 214: 276-84.
28. Muthuraman A, Jaggi AS, Singh N, et al. Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats. Eur J Pharmacol 2008; 587: 104-11.
29. Kaur G, Jaggi AS, Singh N. Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in rats. J Brachial Plex Peripher Nerve Inj 2010; 5: 3.
30. Xiao W, Boroujerdi A, Bennett GJ, et al. Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 2007; 144: 714-20.
31. Flatters SJ, Bennett GJ. Ethosuximide reverses paclitaxel-and vincristine-induced painful peripheral neuropathy. Pain 2004; 109: 150-61.
32. Gauchan P, Andoh T, Kato A, et al. Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice. J Pharmacol Sci 2009; 109: 469-72.
33. Matsumoto M, Inoue M, Hald A, et al. Inhibition of paclitaxelinduced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 2006; 318: 735-40.
34. Adelsberger H, Quasthoff S, Grosskreutz J, et al. The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. Eur J Pharmacol 2000; 406: 25-32.
35. Grolleau F, Gamelin L, Boisdron-Celle M, et al. A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 2001; 85: 2293-7.
36. Webster RG, Brain KL, Wilson RH, et al. Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. Br J Pharmacol 2005; 146: 1027-39.
37. Rutkove SB. Effects of temperature on neuromuscular electrophysiology. Muscle Nerve 2001; 24: 867-82.
38. Bouhours M, Sternberg D, Davoine CS, et al. Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans. J Physiol 2004; 554: 635-47.
39. Krishnan AV, Goldstein D, Friedlander M, et al. Oxaliplatin and axonal Na+ channel function in vivo. Clin Cancer Res 2006; 12: 4481-4.
40. Park SB, Lin CS, Krishnan AV, et al. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain 2009; 132: 2712-23.
41. Nieto FR, Entrena JM, Cendan CM, et al. Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice. Pain 2008; 137: 520-31.
42. Joshi SK, Mikusa JP, Hernandez G, et al. Involvement of the TTXresistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states. Pain 2006; 123: 75-82.
43. Muthuraman A, Singh N. Attenuating effect of hydroalcoholic extract of Acorus calamus in vincristine-induced painful neuropathy in rats. J Nat Med 2011; 65: 480-7.
44. Mangiacavalli S, Corso A, De Amici M, et al. Emergent T-helper 2 profile with high interleukin-6 levels correlates with the appearance of bortezomib-induced neuropathic pain. Br J Haematol 2010; 149: 916-8.
45. Qureshi AA, Hosoi J, Xu S, et al. Langerhans cells express inducible nitric oxide synthase and produce nitric oxide. J Invest Dermatol 1996; 107: 815-21.
46. Deng L, Ding W, Granstein RD. Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells. J Invest Dermatol 2003; 121: 1060-5.
47. Torii H, Yan Z, Hosoi J, et al. Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves. J Invest Dermatol 1997; 109: 586-91.
48. Ledeboer A, Jekich BM, Sloane EM, et al. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun 2007; 21: 686-98.
49. Cata JP, Weng HR, Lee BN, et al. Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol 2006; 72: 151-69.
50. Sweitzer SM, Pahl JL, DeLeo JA. Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat. Neurosci Lett 2006; 400: 258-61.
51. Boyette-Davis J, Dougherty PM. Protection against oxaliplatininduced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Exp Neurol 2011; 229: 353-7.
52. McCarthy BG, Hsieh ST, Stocks A, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995; 45: 1848-55.
53. Ochoa JL, Yarnitsky D. The triple cold syndrome. Cold hyperalgesia, cold hypoaesthesia and cold skin in peripheral nerve disease. Brain 1994; 117 (Pt 1): 185-97.
54. Gedlicka C, Scheithauer W, Schull B, et al. Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid. J Clin Oncol 2002; 20: 3359-61.
55. Joseph EK, Levine JD. Comparison of oxaliplatin-and cisplatininduced painful peripheral neuropathy in the rat. J Pain 2009; 10: 534-41.
56. Kim YS, Son JY, Kim TH, et al. Expression of transient receptor potential ankyrin 1 (TRPA1) in the rat trigeminal sensory afferents and spinal dorsal horn. J Comp Neurol 2010; 518: 687-98.
57. Wang HT, Liu ZG, Yang W, et al. Study on mechanism of bortezomib inducing peripheral neuropathy and the reversing effect of reduced glutathione. Zhonghua Xue Ye Xue Za Zhi 2011; 32: 107-11.
58. Nakano A, Abe M, Oda A, et al. Delayed treatment with vitamin C and N-acetyl-L-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib. Int J Hematol 2011; 93: 727-35.
59. Wang MS, Davis AA, Culver DG, et al. Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 2004; 127: 671-9.
60. Horvath P, Szilvassy J, Nemeth J, et al. Decreased sensory neuropeptide release in isolated bronchi of rats with cisplatin-induced neuropathy. Eur J Pharmacol 2005; 507: 247-52.
61. Jamieson SM, Liu J, Connor B, et al. Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss. Cancer Chemother Pharmacol 2005; 56: 391-9.
62. Tatsushima Y, Egashira N, Kawashiri T, et al. Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin. J Pharmacol Exp Ther 2011; 337: 226-35.
63. Jaggi AS, Singh N. Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain. CNS Neurol Disord Drug Targets 2011; 10: 589-609.
64. Geppetti P, Holzer P. Neurogenic inflammation. Boca Raton: CRC Press 1996.
65. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001; 413: 203-10.
66. Bayliss WM. On the origin from the spinal cord of the vaso-dilator fibres of the hind-limb, and on the nature of these fibres. J Physiol 1901; 26: 173-209.
67. Lewis ST. The nocifensor system of nerves and its reactions. BMJ 1937; 194: 431-5.
68. Nilius B, Owsianik G, Voets T, et al. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87: 165-217.
69. Basbaum AI, Bautista DM, Scherrer G, et al. Cellular and molecular mechanisms of pain. Cell 2009; 139: 267-84.
70. Moqrich A, Hwang SW, Earley TJ, et al. Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science 2005; 307: 1468-72.
71. McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002; 416: 52-8.
72. Peier AM, Reeve AJ, Andersson DA, et al. A heat-sensitive TRP channel expressed in keratinocytes. Science 2002; 296: 2046-9.
73. Jordt SE, Bautista DM, Chuang HH, et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 2004; 427: 260-5.
74. Alessandri-Haber N, Dina OA, Joseph EK, et al. Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia. J Neurosci 2008; 28: 1046-57.
75. Miyano K, Tang HB, Nakamura Y, et al. Paclitaxel and vinorelbine, evoked the release of substance P from cultured rat dorsal root ganglion cells through different PKC isoform-sensitive ion channels. Neuropharmacology 2009; 57: 25-32.
76. Vriens J, Owsianik G, Voets T, et al. Invertebrate TRP proteins as functional models for mammalian channels. Pflugers Arch 2004; 449: 213-26.
77. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 159-212.
78. Szolcsanyi J. A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol (Paris) 1977; 73: 251-9.
79. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-24.
80. Attal N, Bouhassira D, Gautron M, et al. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain 2009; 144: 245-52.
81. Anand U, Otto WR, Anand P. Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat. Mol Pain 2010; 6: 82.
82. Ta LE, Bieber AJ, Carlton SM, et al. Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Mol Pain 2010; 6: 1-15.
83. Patapoutian A, Tate S, Woolf CJ. Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 2009; 8: 55-68.
84. Liedtke W, Choe Y, Marti-Renom MA, et al. Vanilloid receptorrelated osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000; 103: 525-35.
85. Delany NS, Hurle M, Facer P, et al. Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2. Physiol Genomics 2001; 4: 165-74.
86. Wissenbach U, Bodding M, Freichel M, et al. Trp12, a novel Trp related protein from kidney. FEBS Lett 2000; 485: 127-34.
87. Suzuki M, Watanabe Y, Oyama Y, et al. Localization of mechanosensitive channel TRPV4 in mouse skin. Neurosci Lett 2003; 353: 189-92.
88. Guler AD, Lee H, Iida T, et al. Heat-evoked activation of the ion channel, TRPV4. J Neurosci 2002; 22: 6408-14.
89. Grant AD, Cottrell GS, Amadesi S, et al. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol 2007; 578: 715-33.
90. Strotmann R, Harteneck C, Nunnenmacher K, et al. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol 2000; 2: 695-702.
91. Gao X, Wu L, O'Neil RG. Temperature-modulated diversity of TRPV4 channel gating: activation by physical stresses and phorbol ester derivatives through protein kinase C-dependent and-independent pathways. J Biol Chem 2003; 278: 27129-37.
92. Watanabe H, Vriens J, Prenen J, et al. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003; 424: 434-8.
93. Vriens J, Watanabe H, Janssens A, et al. Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4. Proc Natl Acad Sci USA 2004; 101: 396-401.
94. Yoshida T, Inoue R, Morii T, et al. Nitric oxide activates TRP channels by cysteine S-nitrosylation. Nat Chem Biol 2006; 2: 596-607.
95. Watanabe H, Vriens J, Suh SH, et al. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem 2002; 277: 47044-51.
96. O'Neil RG, Leng L. Osmo-mechanically sensitive phosphatidylinositol signaling regulates a Ca2+ influx channel in renal epithelial cells. Am J Physiol 1997; 273: F120-8.
97. Pedersen S, Lambert IH, Thoroed SM, et al. Hypotonic cell swelling induces translocation of the alpha isoform of cytosolic phospholipase A2 but not the gamma isoform in Ehrlich ascites tumor cells. Eur J Biochem 2000; 267: 5531-9.
98. Xu F, Satoh E, Iijima T. Protein kinase C-mediated Ca2+ entry in HEK 293 cells transiently expressing human TRPV4. Br J Pharmacol 2003; 140: 413-21.
99. Alessandri-Haber N, Dina OA, Joseph EK, et al. A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators. J Neurosci 2006; 26: 3864-74.
100. Chen Y, Yang C, Wang ZJ. Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience 2011; 193: 440-51.
101. Alessandri-Haber N, Dina OA, Yeh JJ, et al. Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat. J Neurosci 2004; 24: 4444-52.
102. Alexandre J, Batteux F, Nicco C, et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 2006; 119: 41-8.
103. Materazzi S, Fusi C, Benemei S, et al. TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathionesensitive mechanism. Pflugers Arch 2012; 463.
104. Odell AF, Scott JL, Van Helden DF. Epidermal growth factor induces tyrosine phosphorylation, membrane insertion, and activation of transient receptor potential channel 4. J Biol Chem 2005; 280: 37974-87.
105. Sternfeld L, Anderie I, Schmid A, et al. Identification of tyrosines in the putative regulatory site of the Ca2+ channel TRPV6. Cell Calcium 2007; 42: 91-102.
106. Atoyan R, Shander D, Botchkareva NV. Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin. J Invest Dermatol 2009; 129: 2312-5.
107. Streng T, Axelsson HE, Hedlund P, et al. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 2008; 53: 391-9.
108. Gratzke C, Weinhold P, Reich O, et al. Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells. Eur Urol 2009; 57: 902-10.
109. Earley S, Gonzales AL, Crnich R. Endothelium-dependent cerebral artery dilation mediated by TRPA1 and Ca2+-Activated K+ channels. Circ Res 2009; 104: 987-94.
110. Nozawa K, Kawabata-Shoda E, Doihara H, et al. TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci USA 2009; 106: 3408-13.
111. El Karim IA, Linden GJ, Curtis TM, et al. Human odontoblasts express functional thermo-sensitive TRP channels: implications for dentin sensitivity. Pain 2011; 152: 2211-23.
112. El Karim IA, Linden GJ, Curtis TM, et al. Human dental pulp fibroblasts express the "cold-sensing" transient receptor potential channels TRPA1 and TRPM8. J Endod 2011; 37: 473-8.
113. Kochukov MY, McNearney TA, Fu Y, et al. Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes. Am J Physiol Cell Physiol 2006; 291: C424-32.
114. Mukhopadhyay I, Gomes P, Aranake S, et al. Expression of functional TRPA1 receptor on human lung fibroblast and epithelial cells. J Recept Signal Transduct Res 2011; 31: 350-8.
115. Kwan KY, Allchorne AJ, Vollrath MA, et al. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 2006; 50: 277-89.
116. Sotomayor M, Corey DP, Schulten K. In search of the hair-cell gating spring elastic properties of ankyrin and cadherin repeats. Structure 2005; 13: 669-82.
117. Bautista DM, Jordt SE, Nikai T, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006; 124: 1269-82.
118. Story GM, Peier AM, Reeve AJ, et al. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 2003; 112: 819-29.
119. Sawada Y, Hosokawa H, Matsumura K, et al. Activation of transient receptor potential ankyrin 1 by hydrogen peroxide. Eur J Neurosci 2008; 27: 1131-42.
120. Karashima Y, Talavera K, Everaerts W, et al. TRPA1 acts as a cold sensor in vitro and in vivo. Proc Natl Acad Sci USA 2009; 106: 1273-8.
121. Zurborg S, Yurgionas B, Jira JA, et al. Direct activation of the ion channel TRPA1 by Ca2+. Nat Neurosci 2007; 10: 277-9.
122. Nagata K, Duggan A, Kumar G, et al. Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J Neurosci 2005; 25: 4052-61.
123. Knowlton WM, Bifolck-Fisher A, Bautista DM, et al. TRPM8, but not TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures and cold-mimetics in vivo. Pain 2010; 150: 340-50.
124. del Camino D, Murphy S, Heiry M, et al. TRPA1 contributes to cold hypersensitivity. J Neurosci 2010; 30: 15165-74.
125. Bandell M, Story GM, Hwang SW, et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004; 41: 849-57.
126. Bautista DM, Movahed P, Hinman A, et al. Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci USA 2005; 102: 12248-52.
127. Bang S, Yoo S, Yang T, et al. Nociceptive and proinflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation. Br J Pharmacol 2012; 2012: 1476-5381.
128. McNamara CR, Mandel-Brehm J, Bautista DM, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci USA 2007; 104: 13525-30.
129. Bessac BF, Sivula M, von Hehn CA, et al. Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases. FASEB J 2009; 23: 1102-14.
130. Taylor-Clark TE, Undem BJ. Ozone activates airway nerves via the selective stimulation of TRPA1 ion channels. J Physiol 2009; 588: 423-33.
131. Wang YY, Chang RB, Liman ER. TRPA1 is a component of the nociceptive response to CO2. J Neurosci 2010; 30: 12958-63.
132. Andre E, Campi B, Materazzi S, et al. Cigarette smoke-induced neurogenic inflammation is mediated by alpha, beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest 2008; 118: 2574-82.
133. Matta JA, Cornett PM, Miyares RL, et al. General anesthetics activate a nociceptive ion channel to enhance pain and inflammation. Proc Natl Acad Sci USA 2008; 105: 8784-9.
134. Talavera K, Gees M, Karashima Y, et al. Nicotine activates the chemosensory cation channel TRPA1. Nat Neurosci 2009; 12: 1293-9.
135. Miyamoto T, Dubin AE, Petrus MJ, et al. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One 2009; 4: e7596.
136. Taylor-Clark TE, Undem BJ, Macglashan DW, Jr., et al. Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1). Mol Pharmacol 2008; 73: 274-81.
137. Materazzi S, Nassini R, Andre E, et al. Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. Proc Natl Acad Sci USA 2008; 105: 12045-50.
138. Trevisani M, Siemens J, Materazzi S, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci USA 2007; 104: 13519-24.
139. Taylor-Clark TE, McAlexander MA, Nassenstein C, et al. Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal. J Physiol 2008; 586: 3447-59.
140. Bessac BF, Sivula M, von Hehn CA, et al. TRPA1 is a major oxidant sensor in murine airway sensory neurons. J Clin Invest 2008; 118: 1899-910.
141. Hinman A, Chuang HH, Bautista DM, et al. TRP channel activation by reversible covalent modification. Proc Natl Acad Sci USA 2006; 103: 19564-8.
142. Macpherson LJ, Dubin AE, Evans MJ, et al. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 2007; 445: 541-5.
143. Andersson DA, Gentry C, Moss S, et al. Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J Neurosci 2008; 28: 2485-94.
144. Dai Y, Wang S, Tominaga M, et al. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J Clin Invest 2007; 117: 1979-87.
145. Rigas B, Sun Y. Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. Br J Cancer 2008; 98: 1157-60.
146. Nassini R, Gees M, Harrison S, et al. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor. Pain 2011; 152: 1621-31.
147. Joseph EK, Chen X, Bogen O, et al. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 2008; 9: 463-72.
148. Ramanathan B, Jan KY, Chen CH, et al. Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res 2005; 65: 8455-60.
149. Barriere DA, Rieusset J, Chanteranne D, et al. Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization. Pain 2012; 153: 553-61.
150. Frederick J, Buck ME, Matson DJ, et al. Increased TRPA1, TRPM8, and TRPV2 expression in dorsal root ganglia by nerve injury. Biochem Biophys Res Commun 2007; 358: 1058-64.
151. Gauchan P, Andoh T, Kato A, et al. Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice. Neurosci Lett 2009; 458: 93-5.
152. Descoeur J, Pereira V, Pizzoccaro A, et al. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med 2011; 3: 266-78.
153. Colvin LA, Johnson PR, Mitchell R, et al. From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol. J Clin Oncol 2008; 26: 4519-20.
154. Storey DJ, Colvin LA, Mackean MJ, et al. Reversal of doselimiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery. J Pain Symptom Manage 2010; 39: e2-4.
155. Denk F, McMahon SB. Chronic pain: emerging evidence for the involvement of epigenetics. Neuron 2012; 73: 435-44.
156. Nassini R, Pedretti P, Moretto N, et al. Transient potential ankyrin 1 channel localized to non-neuronal airway cells promotes nonneurogenic inflammation. PLoS One 2012; 7(8): e42454.